In recent decades, non-invasive neuromodulation
methods such as electric and magnetic stimulation of various parts of the nervous system have been increasingly used to rehabilitate patients after a stroke.
As part of the agreement, Abbott will provide the company's neuromodulation
technologies--including directional deep brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy--for research related to these NIH initiatives to explore their application for chronic pain and progressive movement disorders, like Parkinson's disease.
startup Theranica Bio-Electronics has announced OMRON VENTURES has joined its USD 35 million series B funding round to support an approach to migraine management, the company said.
sales are anticipated to be $94M, up 0.6% on a reported basis and an increase of 2.1% for Q1 compared to the same period last year.
Sooma Medical revealed on Friday that it has passed the US patent for its new stimulation electrode for safe and effective delivery of all neuromodulation
The acquisition of the contract design, development, and manufacturing partner to medical device and startup companies with specific expertise in neuromodulation
will enable Heraeus Medical Components to offer a wider and deeper array of neuromodulation
[ClickPress, Thu Sep 06 2018] The report " Neuromodulation
Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020" analyzes and studies the major market drivers, restraints, and opportunities.
LivaNova said the sale will enable it to focus on LivaNova's areas of strength and market leadership in its cardiac surgery and neuromodulation
have expanded the Aziyo Bio Envelope franchise by entering into additional exclusive global license agreements expanding the applications for the Bio Envelope product into the field of neuromodulation
Treatment of idiopathic overactive bladder often requires third-line therapy, which includes onabotulinumtoxinA, posterior tibial nerve stimulation, and sacral neuromodulation
. Until recently, data directly comparing these treatment options were lacking.